Editorial [Hot topic: The Hypoxia-Inducible Factor (HIF) Pathway as a Target for Prevention and Treatment of Clinical Manifestations (Executive Editor: Thomas Kietzmann)]

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|15|33|3837-3838

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.15, Iss.33, 2009-11, pp. : 3837-3838

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial [Hot Topic: The Human Microbiome - A Therapeutic Target for Prevention and Treatment of Chronic Disease (Executive Editor: Kieran Tuohy)]

By  

Current Pharmaceutical Design, Vol. 15, Iss. 13, 2009-05 ,pp. : 1401-1402

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [ Immune-Mediated Mechanisms in Atheroclerosis:Prevention and Treatment of Clinical Manifestations Executive Editor: Emilio Jirillo ]

By  

Current Pharmaceutical Design, Vol. 13, Iss. 36, 2007-12 ,pp. : 3648-3648

Bentham Science Publishers

Access to resources Recommend Favorite

Hypoxia-Inducible Factor-1 (HIF-1): A Potential Target for Intervention in Ocular Neovascular Diseases

By  

Current Drug Targets, Vol. 14, Iss. 8, 2013-07 ,pp. : 919-935

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting hypoxia-inducible factor-1 for therapy and prevention

By Zhong Hua  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 7, 2004-07 ,pp. : 951-966

Informa Healthcare

Access to resources Recommend Favorite

Editorial [Hot Topic: Clinical Management and Treatment of Hypertension, Its Pathophysiology and the Clinical Use of Antihypertensive Drugs (Executive Editor: Gregory Y.H. Lip)]

By  

Current Pharmaceutical Design, Vol. 12, Iss. 13, 2006-05 ,pp. : 1555-1555

Bentham Science Publishers

Access to resources Recommend Favorite